News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Zhejiang Conba Pays $160.5 Million For Majority Stake In Baite Pharma


4/9/2014 2:31:22 PM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

April 8, 2014 -- Zhejiang Conba Pharma will pay $160.5 million to acquire a 51% stake in Guizhou Baite Pharma. Both companies are involved in TCM products, though Conba also makes chemical drugs. The deal is, as Conba points out, its largest M&A transaction since it was listed. Baite’s major product is Danshen Chuanxiongqin injection, a blood thinner used to dissipate clots and treat strokes. More details....

Help employers find you! Check out all the jobs and post your resume.

Read at ChinaBio Today

comments powered by Disqus
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES